Treatment of skin and subcutaneous cancer diseases by hyperthermic methods
Purpose: The present work pursues perfection of highly efficient anticancer, principally new methodology and technology. It deals with the comparative study of anticancer activity of controlled local hyperthermia in animals and determination-de- velopment of optimal regimes and schemes. Furthermore, it also presents the work on new clinical device of high anticancer effect.
Methods: Authors used controlled local hyperthermia for this study. In our experiments, we used 3 to 3.5 months-old non-pedigree (nonlinear) white mice (mass: 18-30 gram). After mice selection for the experiments, animals were placed in vivarium, in quarantine regime for 10 to 4 days. Individual protocols were drawn for each animal. Similar feeding and handling regimes were created for all animals. Transplantable malignant cancer strain, Erlich adenocarcinoma, was used.
Results: Experiments on animals were successful. There are positive conclusions of pathological-anatomy laboratory “PathGeo”: Form # IV -200- 6A, for the examination # 3119-12 and # 15/02 and macro-morphological and micro-morphological description of the study # 15272-13. On the basis of the results of morphological study, it was proved that liver and lungs (the main target bodies) were intact, and secondary cancer injuries were not fixed. After three sessions of hyperthermia treatment, the decrease in sizes of cancer formations and necrosis of diseased sections were visualized, while massive necrosis was observed after seven sessions. In all cases, necrosis and ulceration of diseased places were observed, which refers to transition of cancer into phase of healing. After eight-ten sessions, necrosis of cancer and ulceration were observed, which refers to irreversibility of the process and efficiency of the applied method of hyperthermia.
Conclusion: Anticancer effect of hyperthermia conditioned by temperature fields was proved, which was expressed in inhibition of cancer growth, resorption and increase of life length of experimental animals. The method of treatment was selected with maximum anticancer effect free of side effects and was offered as a new, perspective alternative or additional means for treatment of malignant cancers.
Cavaliere R, Ciocatto EC, Giovanella BC, et al. Selective heat sensitivity of cancer cells. Biochemical and clinical studies. Cancer 1967; 20:1351-81.
Overgaard K, Overgaard J. Investigation on the possibility of a thermic tumour therapy-II: Action of combined heat-roentgen treatment on a transplanted mouse mammary carcinoma. Eur J Cancer 1972; 8:573-5.
Overgaard J. Effect of hyperthermia on malignant cells in vivo. A review and a hypothesis. Cancer 1977; 39:2637-46.
Ehrhardt GJ, Day DE. Therapeutic use of 90Y microspheres. Int J Rad Appl Instrum B 1987; 14:233-42.
Mantravadi RV, Spigos DG, Tan WS, Felix EL. Intraarterial yttrium 90 in the treatment of hepatic malignancy. Radiology 1982; 142:783-6.
Herba MJ, Illescas FF, Thirlwell MP, et al. Hepatic malignancies: improved treatment with intraarterial Y-90. Radiology 1988; 169:311-4.
Wollner I, Knutsen C, Smith P, et al. Effects of hepatic arterial yttrium 90 glass microspheres in dogs. Cancer 1988; 61:1336-44.
Houle S, Yip TK, Shepherd FA, et al. Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheres. Radiology 1989; 172:857-60.
Anderson JH, Goldberg JA, Bessent RG, et al. Glass yttrium-90 microspheres for patients with colorectal liver metastases. Radiother Oncol 1992; 25:137-9.
Burton MA, Gray BN, Jones C, Coletti A. Intraoperative dosimetry of 90Y in liver tissue. Int J Rad Appl Instrum B 1989; 16:495-8.
Shepherd FA, Rotstein LE, Houle S, et al. A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma. Cancer 1992; 70:2250-4.
Andrews JC, Walker SC, Ackermann RJ, et al. Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. J Nucl Med 1994; 35:1637-44.
Tian JH, Xu BX, Zhang JM, et al. Ultrasound-guided internal radiotherapy using yttrium-90-glass microspheres for liver malignancies. J Nucl Med 1996; 37:958-63.
Cao X, He N, Sun J, Tan J, et al. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer. Chin Med J (Engl) 1999; 112:430-2.
Kawashita M, Miyaji F, Kokubo T, et al. Phosphorus-Implanted glass for radiotherapy: Effect of implantation energy. Journal of the American Ceramic Society 1999; 82: 683-8.
Kawashita M, Shineha R, Kim HM, et al. Preparation of ceramic microspheres for in situ radiotherapy of deep-seated cancer. Biomaterials 2003; 24:2955-63.
Hiraoka M, Hahn GM. Comparison between tumor pH and cell sensitivity to heat in RIF-1 tumors. Cancer Res 1989; 49:3734-6.
Borrelli NF, Luderer AA, Panzarino JN. Hysteresis heating for the treatment of tumors. Phys Med Bio 1984; 29: 487-94.
Ohura K, Ikenaga M, Nakamura T, et al. A heat-generating bioactive glass-ceramic for hyperthermia. J Appl Biomater 1991; 2:153-9.
Kokubo T, Ebisawa Y, Sugimoto Y, et al. Preparation of bioactive and ferrimagnetic glass-ceramic for hyperthermia. Bioceramics 1992; 3: 213-23.
Konaka H, Miyaji F, Kokubo T. Preparation and magnetic properties of glass–ceramics containing a-Fe for hyperthermia. J Ceram Soc Jpn 1997; 105: 833-6.
Kawashita M, Takaoka H, Kokubo T, et al. Preparation of magnetite-containing glass-ceramics in controlled atmosphere for hyperthermia of cancer. J Ceram Soc Jpn 2001; 109: 39-44.
Kawashita M, Iwahashi Y, Kokubo T, et al. Preparation of glass-ceramics containing ferrimagnetic Zinc-Iron ferrite for the hyperthermal treatment of cancer. J Ceram Soc Jpn 2004; 112: 373-9.
Kawashita M. Ceramic Microspheres for biomedical applications. International Journal of Applied Ceramic Technology 2005; 2: 173-83.
Kovziridze Z, Donadze G, Mamniashvili G, et al. The receiving and study of hematite nanoparticles for hyperthermia. 1st International Conference for Students and Young Scientists on Materials Processing Science, Journal of Georgian Ceramists Association 2010; 37-46.
Kovziridze Z, Heinrich J, Goerke R, et al. Production of superparamagnetic nanospheres for hyperthermic therapy of surface (skin) cancer diseases. 3rd International congress on Ceramics. IOP Conference Series: Materials Science and Engineering. ICC 3 Proceedings, Innovative Technologies and Future Outlook for Ceramics 2010; 1536-39.
Kovziridze Z, Heinrich J, Goerke R, et al. Production of bionanoceramic superparamagnetics for creation of controlled local hyperthermia and their use, as therapeutic agents, for purposeful transportation in living organisms in surface (skin) cancer treatment. Journal of Georgian Ceramists Association “Ceramics” 2010; 43-51.
Kovziridze Z, Khorava P, Mitskevich N. Controlled local hyperthermia and magnetic hyperthermia of surface (Skin) cancer diseases. Journal of Cancer Therapy 2013; 4: 1262-71.
Kovziridze Z, Nikoleishvili E, P. Khorava P, et al. Controlled local hyperthermia for therapy of malignancies. 2nd International Conference for Students and Young Scientists on Materials Processing Science. Journal of Georgian Ceramists Association 2013; 140-6.
Kovziridze Z, Khorava P, Zerekidze l, et al. Development of hyperthermal method for treatment of malignancies. Journal of Georgian Ceramists Association “Ceramics” 2012;16-34
Donadze G, Mamniashvili G, Akhalkatsi A, et al. The receiving and study of hematite, nanoparticles for hyperthermia. 1st International Conference for Students and Young Scientists on Materials Processing Science. Journal of Georgian Ceramists Association “Ceramics” 2011; 37-46.
This work is licensed under a Creative Commons Attribution 3.0 License.
International Journal of Cancer Therapy and Oncology (ISSN 2330-4049)
© International Journal of Cancer Therapy and Oncology (IJCTO)
To make sure that you can receive messages from us, please add the 'ijcto.org' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.